Top Biotechnology companies in Switzerland by Share Price

This ranking features the top 23 Biotechnology companies in Switzerland ranked by Share Price, totalling a Share Price of USD 4.18 K, for January 15, 2025.
#
Name
Share Price
Reported Date
Stock Price
Change
Price (30 days) Country
1

USD 1.16 K

Jan. 14, 2025 USD 1.16 K 0.97%

Switzerland

2

USD 1.04 K

Jan. 14, 2025 USD 1.04 K -2.38%

Switzerland

3

USD 588.68

Jan. 14, 2025 USD 588.68 -0.80%

Switzerland

4

USD 355.46

Jan. 14, 2025 USD 355.46 -1.48%

Switzerland

5

USD 244.50

Jan. 14, 2025 USD 244.50 0.95%

Switzerland

6

USD 229.49

Jan. 14, 2025 USD 229.49 0.50%

Switzerland

7

USD 98.71

Jan. 14, 2025 USD 98.71 -0.26%

Switzerland

8

USD 97.52

Jan. 14, 2025 USD 97.52 0.29%

Switzerland

9

USD 61.01

Jan. 14, 2025 USD 61.01 0.32%

Switzerland

10

USD 46.50

Jan. 14, 2025 USD 46.50 2.74%

Switzerland

11

USD 44.53

Jan. 14, 2025 USD 44.53 -0.85%

Switzerland

12

USD 42.16

Jan. 14, 2025 USD 42.16 0.08%

Switzerland

13

USD 41.74

Jan. 14, 2025 USD 41.74 4.19%

Switzerland

14

USD 38.36

Jan. 14, 2025 USD 38.36 -1.26%

Switzerland

15

USD 27.99

Jan. 14, 2025 USD 27.99 -3.47%

Switzerland

16

USD 24.15

Jan. 14, 2025 USD 24.15 -4.07%

Switzerland

17

USD 22.44

Jan. 14, 2025 USD 22.44 0.27%

Switzerland

18

USD 7.39

Jan. 14, 2025 USD 7.39 -3.40%

Switzerland

19

USD 5.48

Jan. 14, 2025 USD 5.48 3.60%

Switzerland

20

USD 2.61

Jan. 14, 2025 USD 2.61 NA

Switzerland

21

USD 2.41

Jan. 14, 2025 USD 2.41 0.50%

Switzerland

22

USD 2.03

Jan. 14, 2025 USD 2.03 -1.93%

Switzerland

23

USD 1.71

Jan. 14, 2025 USD 1.71 -0.58%

Switzerland

Frequently Asked Questions
  • Which Biotechnology company in Switzerland has the highest Share Price ?

    The Biotechnology company in Switzerland with the highest Share Price is Metall Zug AG (Swiss Stock Exchange: METN.SW) at USD 1.16 K.

  • Which Biotechnology company in Switzerland has the lowest Share Price ?

    The Biotechnology company in Switzerland with the lowest Share Price is ADC Therapeutics SA (NYSE: ADCT) at USD 1.71.